PD173074 is a potent inhibitor of FGFR1 and VEGFR, and it was also shown to effectively resensitize chemoresistant cancer cells overexpressing ABCB1 and ABCC10 to some chemotherapeutic agents, including paclitaxel. The gene discussed is KDR; the disease is cancer.